Pfizer First: Oral Antiviral Paxlovid Wins EUA As Merck’s COVID Pill Languishes At US FDA

 
• By Sue Sutter
  
Crossing finish line
Pfizer beat Merck & Co./Ridgeback to the EUA finish line for COVID-19 oral antiviral treatments. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Review Pathways

More from Pathways & Standards